Plain-English translation of NCT04504188 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study tests whether using continuous heart rate information from a wearable heart monitor device can help doctors better adjust your heart medications — specifically beta blockers and ivabradine — to keep your heart rate at a healthy level. Women with cardiomyopathy (a condition where the heart muscle is weakened) will wear an FDA-approved wearable defibrillator for about 3 months while doctors use real-time heart rate data to optimize the medication.
Women with weakened heart muscle often struggle to get their heart rate to the recommended safe level with standard medication adjustments. This trial tests whether using continuous heart rate monitoring from a wearable device can help doctors fine-tune medications more effectively, potentially improving outcomes.
You likely qualify if…
You likely don't qualify if…
You will wear an FDA-approved wearable heart defibrillator for 3 months. The device continuously monitors your heart rate and sends reports to your doctor every 2 weeks showing your daily heart rate patterns. Your doctor will use this information to adjust your heart medications as needed to help your heart rate reach a healthier goal. The study lasts about 3 months total, and your main responsibility is to wear the device consistently during that time.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States